3Nazli A,Yang PC,Jury J,et al.Epithelia under metabolic stress perceive commensal bacteria as a threat[J].Am J Pathol,2004 ,164(3):947-57.
4Lewis JD,Aberra FN,Lichtenstein GR,et al.Seasonal variation in flares of inflammatory bowel disease[J].Gastroenterology,2004,126(3):665-73.
5Whary MT,Fox JG.Th1-mediated pathology in mouse models of human disease is ameliorated by concurrent Th2 responses to parasite antigens[J].Curr Top Med Chem,2004,4(5):531-8.
8Berrebi D,Maudinas R,Hugot JP,et al.Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon[J].Gut,2003,52:840-6.
9Lala S,Ogura Y,Osborne C,et al.Crohn's disease and the NOD2 gene:a role for paneth cells[J].Gastroenterology,2003,125:47-57.
10Scheinin T,Butler DM,Salway F,et al.Validation of the interleukin-10 knockout mouse model of colitis: antitumour necrosis factor-antibodies suppress the progression of colitis[J].Clin Exp Immunol,2003,133:38-43.
二级参考文献51
1Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology, 1998, 115(1): 182-205.
2Van Deventer SJ. The future of inflammatory bowel disease therapy, lnflamm Bowel Dis, 2002, 8(4) :301 - 305.
3Sartor RB. Pathogenesis and immune mechanisms d chronic inflammatory bowel disease. Am J Gastroenterol, 1997, 92(12 Suppl):5 - 11.
4Guimbaud R, Bertrand V, Chauvelot-Moachon L, et al. Network of inflammatory cytokines and correlation with disease activity in ulcerative colitis. Am .I Gastroenterol. 1998,93(12) : 2397 - 2404.
6Ikeda Y, Akbar SM, Matsui H, Onji M. Antigen-presenting dendritic cells in ulcerative colitis. J Gastroenterol 2002;37(Suppl 14):53-55.
7Bamias G, Marini M, Moskaluk CA, Odashima M, Ross WG,Rivera-Nieves J, Cominelli F. Down-regulation of intestinal lymphocyte activation and Thl cytokine production by antibiotic therapy in a murine model of Crohn's disease. J Immunol 2002;169:5308-5314.
8Sawa Y, Oshitani N, Adachi K, Higuchi K, Matsumoto T,Arakawa T. Comprehensive analysis of intestinal cytokine messenger RNA profile by real-time quantitative polymerase chain reaction in patients with inflammatory bowel disease.Int J Mol Med 2003;11:175-179.
9Lakatos L. Immunology of inflammatory bowel diseases. Acta Physiol Hung 2000;87:355-372.
10Hata K, Andoh A, Sato H, Araki Y, Tanaka M, Tsujikawa T,Fujiyama Y, Bamba T. Sequential changes in luminal microflora and mucosal cytokine expression during developing of colitis in HLA-B27/beta2-microglobulin transgenic rats. Scand J Gastroenterol 2001;36:1185-1192.
